Publication | Open Access
Age-Dependent Neutralization of SARS-CoV-2 and P.1 Variant by Vaccine Immune Serum Samples
107
Citations
6
References
2021
Year
ImmunologyVaccine HesitancyCovid-19Preventive MedicineBnt162b2 VaccineVaccine SurveillanceVaccinologyVaccine SafetyVaccine DevelopmentP.1 VariantCovid-19 PandemicVaccine TestingAge-dependent NeutralizationPatient AgeEpidemiologyVaccinationPrecision VaccinologyVaccine EfficacyMedicine
Vaccination with 2 doses of the BNT162b2 vaccine (Pfizer-BioNTech) reportedly provides 95% protection from COVID-19. 1 However, patient age is known to contribute to the risk of
| Year | Citations | |
|---|---|---|
Page 1
Page 1